SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-017764
Filing Date
2017-07-05
Accepted
2017-07-05 16:07:05
Documents
2
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4040
2 EX-24 DOCUMENT attachment1.htm EX-24 4174
  Complete submission text file 0000899243-17-017764.txt   9714
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Issuer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TOKAI PHARMACEUTICALS, INC. ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address
McBride John S. (Reporting) CIK: 0001618251 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36620 | Film No.: 17947997